Canada's Genesys leverages strong exit multiples in launch of C$150 mln fund

Toronto-based Genesys Capital focuses on early-stage healthcare and biotech companies

15 June 2015•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail